Clinical trial
Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study
NCT03128762
Study timeline
Study start (actual)2014-06-25Date precision: day
Registry last updated2017-05-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
ILC2 levels in bloodBIOLOGICAL
Sponsors & collaborators
University Hospital, Montpellierlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03128762 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.